Evidence map›Paper›PMID 31385966›Full record

ArticleNeuro-oncology practice2017

Development of an item bank for computerized adaptive testing of self-reported cognitive difficulty in cancer patients.

Linda Dirven, Martin Jb Taphoorn, Mogens Groenvold, Esther Jj Habets, Neil K Aaronson, Thierry Conroy, Jaap C Reijneveld, Teresa Young, Morten Aa Petersen, EORTC Quality of Life Group

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neuro-oncology practice, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. International validation of the EORTC CAT Core: a new adaptive instrument for measuring core quality of life domains in cancer.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2020
    Article
  5. Psychometric evaluation of an item bank for computerized adaptive testing of the EORTC QLQ-C30 cognitive functioning dimension in cancer patients.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Linda DirvenDepartment of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
Martin Jb TaphoornDepartment of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
Mogens GroenvoldDepartment of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
Esther Jj HabetsDepartment of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
Neil K AaronsonDepartment of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
Thierry ConroyDepartment of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
Jaap C ReijneveldDepartment of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
Teresa YoungDepartment of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
Morten Aa PetersenDepartment of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
EORTC Quality of Life Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group is developing computerized adaptive testing (CAT) versions of each scale of the EORTC Quality of Life Questionnaire (EORTC QLQ-C30). This study aims to develop an item bank for the EORTC QLQ-C30 cognitive functioning scale, which can be used for CAT.

methodsThe complete developmental approach comprised four phases: (I) conceptualization and literature search, (II) operationalization, (III) pretesting, and (IV) field-testing. This paper describes phases I-III.I) A literature search was performed to identify self-report instruments and items measuring cognitive complaints on concentration and memory. II) A multistep item-selection procedure was applied to select and generate items that were relevant and compatible with the 'QLQ-C30 item style.' III) Cancer patients from different countries evaluated the item list for wording (ie, whether items were difficult, confusing, annoying, upsetting or intrusive), and whether relevant issues were missing.

resultsA list of 439 items was generated by the literature search. In the multistep item-selection procedure, these items were evaluated for relevance, redundancy, clarity, and response format, resulting in an list of 45 items. A total of 32 patients evaluated this item list in the pretesting phase, resulting in a preliminary list of 44 items.

conclusionPhase I-III resulted in an item list of 44 items measuring self-reported cognitive complaints that was endorsed by international experts and cancer patients in several countries. This list will be evaluated for its psychometric characteristics in phase IV.

Indexed as

cancercognitive functioningcomputerized adaptive testinghealth-related quality of lifeitem bank

Identifiers

PMID31385966
PMCPMC6655367

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.